ABBV vs UAMY · P/E 81, rev $61.16B vs rev $14.9M
AbbVie Inc (ABBV) versus United States Antimony Corporation (UAMY) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
United States Antimony Corporation (UAMY) is a other industrial metals & mining company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported UAMY revenue for 2024-12-31 was $14.9M. Net income was -$1.7M. Revenue was up 71.8% from 2023-12-31 to 2024-12-31. UAMY currently screens at market cap $1.14B.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. UAMY currently screens at market cap $1.14B.
Not investment advice. Open the ABBV and UAMY stock pages for the full models.
Not investment advice.